CD160 and COVID-19: In moderate cases of COVID-19, previous research has shown that an expansion of CD160+ ‘NKT-type’ cells has been observed, which may help promote rapid resolution of infection through direct cytotoxicity, but the NKT CD160 cluster was notably absent in severe COVID-19 cases37.